Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CSAQ | ISIN: GB00BK80TJ35 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PHYSITRACK PLC Chart 1 Jahr
5-Tage-Chart
PHYSITRACK PLC 5-Tage-Chart
ACCESS Newswire
375 Leser
Artikel bewerten:
(2)

Physitrack Plc Announces Enhanced Integration with Largest US Hospital EMR Provider in Collaboration with US-Based Hospital Group

LONDON, UK / ACCESS Newswire / February 21, 2025 / Physitrack PLC (STO:PTRK), a leading provider of digital health solutions, today announces the development of a new feature for its flagship home exercise prescription platform as part of a €25,000 sponsored development deal with a US-based hospital group. The feature will enable a seamless back-end integration between the Physitrack platform and the most widely used electronic medical record (EMR) system in the US hospital operator market, ensuring that patient data and documents are effortlessly shared between the two systems.

This integration enhances the efficiency and accessibility of patient information for healthcare providers by introducing tailored flow sheets that capture relevant data from the Physitrack platform and add them directly as patient notes within the EMR. Additionally, PDF integration centralizes document management, streamlining workflows and improving collaboration across care teams.

Henrik Molin, CEO of Physitrack, commented:

"We are delighted to announce this development, which not only strengthens our collaboration with a major hospital group but also enhances the functionality of our platform in a way that benefits healthcare providers and patients alike. By integrating seamlessly with the biggest EMR provider in the US hospital space, we are furthering our mission to drive digital transformation in healthcare, making it easier for providers to manage patient care efficiently."

These sponsored development projects are of strategic importance to Physitrack as they drive innovation and expand the platform's feature set while strengthening integration with a major EMR provider. Such integrations open doors to broader commercial distribution opportunities while simultaneously benefiting all stakeholders. This deal represents a win-win-win scenario:

  • The US hospital provider gains enhanced functionality, improving patient data accessibility.

  • Physitrack generates revenue specifically for the development of the feature while strengthening the value of its distribution potential through the EMR provider.

  • The wider EMR-based user base benefits from an improved platform with an expanded feature set.

This latest development underscores Physitrack's commitment to advancing digital health solutions that empower healthcare providers with seamless, efficient, and scalable technology.

A Spotlight interview on the subject with CEO & co-founder Henrik Molin can be found here:
https://vimeo.com/1059008867/b415a97589

Enquiries regarding this announcement should be addressed to:

Henrik Molin, CEO and co-founder, Physitrack.
+44 208 133 9325
ir@physitrack.com
media@physitrack.com

About Physitrack

Physitrack PLC, founded in 2012, is a global digital healthcare provider, focused on the B2B wellness and virtual-first care markets. With staff with 12 nationalities on four continents, customers in 17 time zones, and end users in 187 countries, Physitrack is a truly global company.

The company has two business lines:
1. Lifecare - SaaS platform tailored mainly to physiotherapy and musculoskeletal care, enabling practitioners to deliver clinical home exercises, education prescription, outcomes tracking, triaging and Telehealth.
2. Wellness / Champion Health - SaaS platform for Employee Wellness and care powered by a combination of world-leading technology and wellness professionals based in the United Kingdom, Germany and the Nordics.

Physitrack PLC is headquartered in London, United Kingdom, and listed on Nasdaq First North Premier Growth Market (PTRK).

Visit us at
https://physitrackgroup.com/ (investor relations)
https://physitrack.com (product marketing)

About Champion Health

Champion Health, a subsidiary of Physitrack Plc, is a leader in corporate wellness technology, providing an innovative platform that empowers businesses to support their employees' well-being through personalised wellness action plans and advanced analytics.

Visit us at
https://championhealth.co.uk/

Attachments

Physitrack Plc Announces Enhanced Integration with Largest US Hospital EMR Provider in Collaboration with US-Based Hospital Group

SOURCE: Physitrack PLC



© 2025 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.